A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：NEUROREHABILITATION AND NEURAL REPAIR ISSN： 1545-9683 出版频率： Monthly 出版社： SAGE PUBLICATIONS INC, 2455 TELLER RD, THOUSAND OAKS, USA, CA, 91320   出版社网址： http://online.sagepub.com/ 期刊网址： http://nnr.sagepub.com/ 影响因子： 3.919 主题范畴： CLINICAL NEUROLOGY;    REHABILITATION 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal     The Journal will consider for publication original articles and reviews on both basic science and clinical research relevant to recovery from neural injury. Examples of appropriate topics include cortical remodeling, mechanisms of sprouting and regeneration, the development of cell lines for transplantation and trophic factor replacement, strategies to promote functional recovery in human patients, design of outcome measures in neurologic rehabilitation, the multidisciplinary management of neurologic disease, and bioengineering and assistive devices used in the management of neurologic impairment. Neurorehabilitation & Neural Repair offers neurologists, neurosurgeons, physiatrists, rehabilitation nurses, discharge planners, social workers, basic scientists working in neural regeneration and plasticity, and physical, occupational, and speech therapists innovative and reliable reports relevant to functional recovery from neural injury and long term neurologic care.  The journal's unique focus is evidence-based basic and clinical practice and research. NNR deals with the management and fundamental mechanisms of functional recovery from conditions such as stroke, multiple sclerosis, cerebral palsy, Parkinson’s disease and other movement disorders, Alzheimer’s disease and dementia, traumatic and acquired brain injuries and related secondary conditions, spinal cord injuries, and peripheral nerve injuries. Some of the key topics covered in recent issues include cortical remodeling after stroke, traumatic brain injury or spinal cord injury studied by transcranial magnetic stimulation and functional magnetic resonance imaging, mechanisms of sprouting and regeneration, development of cell lines for transplantation and trophic factor replacement strategies to promote functional recovery in human patients, multidisciplinary management of neurologic disease, bioengineering and assistive devices used in the management of neurologic impairment or pain syndromes, pharmacological management of multiple sclerosis, pharmacology of motor recovery, cognitive rehabilitation, and design of randomized multicenter trials in neurorehabilitation. The journal carries articles designed to appeal to a variety of audiences: clinical practice, research, brief communications, case reports, reviews, and media reviews.   Instructions to Authors   Submission Manuscript Guidelines: SCOPE: Neurorehabilitation and Neural Repair will consider for publication original manuscripts, in other words, those that have not been published elsewhere except in abstract form, on any topic, clinical or basic science, that is relevant to recovery from neural injury and long-term neurologic care. Appropriate topics include, but are not limited to, fundamental mechanisms of functional recovery, neural reorganization and regeneration, transplantation of fetal neural tissue, stem cells and genetically modified cells to pro-mote functional recovery, epidemiology and longitudinal studies of neural injury and chronic neurologic disorders, outcome measures in neurologic rehabilitation, multidisciplinary approaches to recovery from chronic neurologic disorders, and bioengineering and assistive devices used in the management of neurologic impairment. Expedited review and publication is possible for suitable manuscripts at the request of the author. ADDRESS FOR CONTRIBUTIONS Michael E. Selzer, MD, PhD, Editor-in-Chief Neurorehabilitation and Neural Repair Department of Neurology University of Pennsylvania Medical Center 3400 Spruce Street Philadelphia, PA 19104-4283 Telephone: (215) 662-3396 Fax: (215) 573-2107 E-mail: nnr@mail.med.upenn.edu FORM OF MANUSCRIPTS: Three typewritten copies of each manuscript must be submitted, in English, double-spaced throughout with a 2.5 cm (1 inch) left margin. One disk (either DOS or Mac, 3?inch preferred) containing a copy of the manuscript should accompany the manuscript. If a word processor is used, do not justify right hand margins. The authors should retain a copy for reference as accepted manuscripts will not be returned. All accepted manuscripts will be subject to copyediting. Refer to patients by number (or, in anecdotal reports, by fictitious given names). Real names or initials should not be used in the text, tables, or illustrations. The title page of each manuscript should include (a) the title of the article, (b) the names and full affiliations of all authors, (c) the name, mailing address, and telephone number of the person to whom proofs and reprint requests should be addressed, and (d) a running title not exceeding 42 letters and spaces. Full length original research articles should have an Abstract, Introduction, Methods, Results, and Discussion. Review articles should have an Abstract, but the organization of the body of text is flexible. Brief communications and case reports should be labeled as such. They will be considered if they make a significant new observation and are not merely an excuse to review the literature. They must be 10 or fewer double spaced typed pages in length, including references, and have three or fewer figures or tables. Brief communications and case reports should include an Abstract, but subdivision into Introduction, Methods, Results and Discussion is optional. Images in Neurorehabilitation: Neurorehabilitation and Neural Repair will consider photographic, radiographic or artistic images that have exceptional visual impact and have relevance to neurologic rehabilitation. These images should make up a single figure, although they may contain more than one frame. Accompanying text must be one page or less of double-spaced type. Abstract: Abstracts may contain up to 200 words. For original research articles and brief communications the abstract should be structured with the following subheadings: Objective, Methods, Results, Conclusions. Up to six key words or terms should be included for use by referencing sources. Acknowledgments: Acknowledgments should be made at the end of the text. They should include a listing of grant support and disclosure of any commercial interest of the authors relevant to the subject of the manuscript. Personal acknowledgments should be kept to a minimum. Tables and Illustrations: All tables should have a title and should be typed double-spaced, including all headings, each on a separate page. All abbreviations should be defined. Illustrations should be submitted as clear glossy prints (two duplicate sets may be photocopies), with lettering large enough to be legible when the figure is reduced to column size. The figure number, name of author, and an arrow indicating "top" should be indicated on the back of each figure. Where possible, copies of artwork should be submitted on disc as TIFF or EPS files, using an illustration program such as Adobe Illustrator or Photoshop. This will permit minor revisions to be made in press without the need for authors to remake figures. All color illustrations will be charged to authors. Figure Legends should be typed as a continuous, double-spaced list, beginning on a separate sheet of paper. DETAILS OF STYLE General: An important goal of Neurorehabilitation and Neural Repair is to foster communication between the basic and clinical research communities whose work is relevant to recovery from neural injury. Therefore, basic science articles should include sufficient explanatory information in the Introduction and elsewhere to permit reading by clinician readers, and vice versa. All abbreviations and jargon terms should be defined and kept to a minimum. The rationale and significance of the reported research should be explained in terms of its relevance to recovery of neurological function. At the end of Discussion, a sub-heading Implications may be added. Slightly greater latitude to speculate on clinical implications of basic research findings will be permitted here. Clinical researchers may use this subheading to suggest what basic science advances would be needed in order to move the clinical research to the next level. Drug Names: Use generic names only in referring to drugs, followed in parentheses after first mention by any commonly used variant generic and/or brand names. Abbreviations: Follow the Council of Biology Editors Style Manual or other standard sources. For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus. References: The reference style of the journal is that given in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (see JAMA 1997; 277:927?4). Cite references in the text by number, and number them in the order in which they are cited. Type the reference section double-spaced at the end of the text, following the examples given below. For abbreviations, refer to List of Journals Indexed in Index Medicus [DHEW Publication No. (NIH) 83-267; ISSN 0093-3821], available from the Superintendent of Documents, US Government Printing Office, Washington, DC 20402, USA. For each reference, provide all authors?names when fewer than 7; when 7 or more, list the first 3 and add et al. Be sure to provide the title of each article and inclusive pages. Accuracy of reference data is the responsibility of the author. SAMPLE REFERENCES Journal Article: 1. Doherty P, Dickson JG, Flanigan TP, Kennedy PGE, Walsh FS. Effects of amyotrophic lateral sclerosis serum on cultured chick spinal neurons. Neurology 1986;36:1330-4. Book: 2. Schapiro RT. Symptom management in multiple sclerosis. New York: Demos; 1993. Chapter in Book: 3. Volow MR. Psychiatric aspects of blepharospasm. In: Bosniak SL, ed. Blepharospasm. New York: Pergamon Press; 1981:163-74. (Advances in ophthalmic plastic and reconstructive surgery; vol. 4.) PHOTOGRAPHIC CONSENTS: A letter of consent must accompany all photographs of patients in which the possibility of identification exists. It is not sufficient to cover the eyes to mask identity. COVER LETTER: A cover letter must accompany the manuscript explaining any duplication or overlap in content with a previously published article, or stating that no part of the work has been published. Where relevant, the letter must state that the project was approved by an authorized institutional human research review board or institutional animal research authority. The letter should identify any commercial interest of the authors relevant to the subject of the manuscript, or state that no such conflict of interest exists. PROOFS: Proofs must be returned within 3 days of receipt; late return may cause a delay in publication of an article. Please check text, tables, legends, and references carefully. To expedite publication, authors will receive page proofs rather than galley proofs for review; it is therefore essential that corrections be kept to an absolute minimum. Changes or additions in page proof that exceed 10% of the article length will be charged to the author. REPRINTS: An order form for reprints will be included with proofs. Mail proof and reprint order form to Customer Care Department, Sage Publications, 2455 Teller Road, Thousand Oaks, CA 91320. Phone (800) 818-7243; Fax (805) 499-0871. Email: order@sagepub.com   Editorial Board     Editor:  Michael E Selzer, MD, PhD University of Pennsylvania School of Medicine Assistant Editor Richard D. Zorowitz, MD, University of Pennsylvania Medical Center  Book Review Editor Douglas I. Katz, Boston University School of Medicine, Massachusetts  Associate Editors Neils Birbaumer, PhD, Eberhard-Karls-University  Stephanie Clarke, MD, University of Lausanne  Leonardo Cohen, MD, National Institutes of Health  Bruce H. Dobkin, MD, University of California-Los Angeles  Steven Dunnett, PhD, Cardiff University  Hans-Peter Hartung, MD, Heinrich-Heine-University Dusseldorf  Linda Michaud, MD, University of Cincinnati  Louis Quatrano, PhD, National Institute of Health  Carol Richards, PhD, University of Laval  Alan J. Thompson  Derick Wade, Oxford Centre for Enablement  Richard D. Zorowitz, MD, University of Pennsylvania Medical Center  Editorial Board Members Albert J. Aguayo, MD, McGill University, Montreal, Canada   Mindy L. Aisen, MD, Department of Veterans' Affairs  Michael A. Alexander, MD, Alfred I. duPont Institute  Richard W. Bohannon, EdD, PT, NCS, University of Connecticut  John Chae, MD, Case Western Reserve University  Naoichi Chino, Keio University School of Medicine  Rory Cooper, PhD, University of Pittsburgh  Mark D'Esposito, MD, University of California, Berkeley (Emeritus)  Alexander W. Dromerick, MD, Washington University School of Medicine  Pamela W. Duncan, PhD, PT, VAMC, Gainesville  Thierry M. Ettlin, MD, University Hospital Basel  Fred H. Gage, The Salk Institute  David C. Good, MD, Wake Forest University  Harry G. Goshgarian, PhD, Wayne State University School of Medicine  Mark Hallett, MD, National Institute of Neurological Disorders and Stroke  June Halper, MSN, RN, CS, ANP, Holy Name Hospital  Susan Langmore, PhD, Medical Anthropology, University of California, San Francisco  Virginia M.-Y. Lee, PhD, University of Pennsylvania  Jeri A. Logemann, PhD, Northwestern University  Thomas A. Matyas, PhD, La Trobe University  Karl H. Mauritz, MD, Klinik Berlin  Mark F. Mehler, MD, Albert Einstein College of Medicine, New York  Marion Murray, PhD, Medical College of Pennsylvania  T. Jock Murray, MD, Dalhousie University  Randolph J. Nudo, PhD, University of Kansas  Werner Poewe, MD, University Hospital Innsbruck  Geoffrey Raisman, MD, PhD, National Institutes of Medical Research  Michael J. Reding, MD, Burke Rehabilitation Hospital  Elliot Roth, MD, Northwestern University  Timothy Schallert, PhD, The University of Texas at Austin  Martin E. Schwab, PhD, Swiss Federal Institute of Technology, Zurich, Switzerland  Alan R. Tessler, MD, Medical College of Pennsylvania  Wolfram Tetzlaff, MD, PhD, University of British Columbia  Mark H. Tuszynski, MD, PhD, Graduate School of International Relations and Pacific Studies, University of California, San Diego  Barbara G. Vickrey, MD, MPH, University of California-Los Angeles  Bruce T. Volpe, MD, Cornell University  Stephen G. Waxman, MD, PhD, Yale University School of Medicine, New Haven, Connecticut USA  Ian Whishaw, PhD, University of Lethbridge  Steven Wolf, PhD, Emory University School of Medicine  Takehiko Yanagihara, MD, Osaka University, Japan